Site-Specific Protein Ubiquitylation Using an Engineered, Chimeric E1 Activating Enzyme and E2 SUMO Conjugating...

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Ubiquitylation is a crucial post-translational modification involving ubiquitin (Ub) attachment to proteins.
• Existing methods like lysine acylation using conjugating enzymes (LACE) face limitations such as slow kinetics and requirement for ubiquitin thioesters.
• These limitations restrict LACE to in vitro applications and hinder efficient protein ubiquitylation.

Purpose of the Study:

• To overcome the limitations of existing ubiquitylation methods.
• To develop an improved system for site-specific protein ubiquitylation.
• To enable facile preparation of monoubiquitylated proteins.

Main Methods:

• Devised a chimeric E1 enzyme combining SUMO E1 and Ub E1 domains.
• Utilized directed evolution to enhance the chimeric E1's catalytic efficiency (kcat/KM) 400-fold.
• Demonstrated site-specific transfer of mono- and oligo-ubiquitin to target proteins in vitro.
• Coexpressed the chimeric E1, Ubc9, Ub, and target protein in E. coli for in vivo preparation.

Main Results:

• The chimeric E1 activates and loads native ubiquitin onto Ubc9, eliminating the need for ubiquitin thioesters.
• Directed evolution significantly improved the chimeric E1's performance.
• Successful site-specific ubiquitylation of various proteins was achieved in vitro.
• Facile preparation of monoubiquitylated proteins was demonstrated through coexpression in E. coli.

Conclusions:

• The developed chimeric E1 enzyme significantly enhances the efficiency and applicability of site-specific ubiquitylation.
• This novel system overcomes key limitations of previous methods, enabling both in vitro and in vivo applications.
• The findings provide a valuable tool for studying ubiquitylation and producing modified proteins.